Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Non Operating Income (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Non Operating Income for 2 consecutive years, with -$97000.0 as the latest value for Q4 2020.

  • Quarterly Non Operating Income rose 42.26% to -$97000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$346000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at -$366000.0 for FY2020, 69.44% down from the prior year.
  • Non Operating Income for Q4 2020 was -$97000.0 at Pliant Therapeutics, down from $55000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $55000.0 in Q3 2020, with the low at -$168000.0 in Q4 2019.